Common Contracts

FORM OF Series I Warrant to purchase Common Stock

Windtree Therapeutics Inc /De/ • May 6th, 2020 • Biological products, (no disgnostic substances) • Delaware

• Company
  Windtree Therapeutics Inc /De/
• Filed
  May 6th, 2020
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  Delaware

This amendment No. 1 to the SERIES I WARRANT TO PURCHASE COMMON STOCK (this “Agreement”) is made as of May 6, 2020, by and between Windtree Therapeutics, Inc., a Delaware corporation (the “Company”) and the undersigned holder (“Holder”). The Company and the Holder are sometimes referred to herein collectively as the “Parties” and individually as a “Party.”